Siga Technologies (SIGA) Net Cash Flow Growth (3y) (2013 - 2025)
Siga Technologies (SIGA) Net Cash Flow Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -28.90% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -5.41% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 19.55% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 95.24% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -106.21% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 4.40% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 17.73% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Siga Technologies | 213.38 Mn | 58.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -30.01% |
| Jun 30, 2025 | 36.11% |
| Mar 31, 2025 | -48.44% |
| Dec 31, 2024 | 75.87% |
| Sep 30, 2024 | -10.67% |
| Jun 30, 2024 | -66.20% |
| Mar 31, 2024 | 17.95% |
| Dec 31, 2023 | 26.30% |
| Sep 30, 2023 | -30.04% |
| Jun 30, 2023 | -17.53% |
| Mar 31, 2023 | 30.10% |
| Dec 31, 2022 | 10.41% |
| Sep 30, 2022 | -181.64% |
| Jun 30, 2022 | -107.29% |
| Mar 31, 2022 | 863.50% |
| Dec 31, 2021 | -47.74% |
| Sep 30, 2021 | -27.38% |
| Jun 30, 2021 | -15.43% |
| Mar 31, 2021 | -9.89% |
| Dec 31, 2020 | 87.54% |